Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1293610.RAzr1hLyVGtVl15vGXlGFz3mjnmiWgQ_kBbWSE5aLyc3w130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1293610.RAzr1hLyVGtVl15vGXlGFz3mjnmiWgQ_kBbWSE5aLyc3w130_assertion type Assertion NP1293610.RAzr1hLyVGtVl15vGXlGFz3mjnmiWgQ_kBbWSE5aLyc3w130_head.
- NP1293610.RAzr1hLyVGtVl15vGXlGFz3mjnmiWgQ_kBbWSE5aLyc3w130_assertion description "[When compared with the wild-type genotype, the variant genotypes rs5767743 and rs5767700 correlated with significantly increased PPAR? and CYP3A4 mRNA expression and lower tacrolimus trough concentration/dose ratios (P < 0.05 for all).Donor PPAR? gene polymorphisms influence the susceptibility to metabolic disorders following LT and may also be associated with a fasten tacrolimus metabolism because of elevated CYP3A4 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1293610.RAzr1hLyVGtVl15vGXlGFz3mjnmiWgQ_kBbWSE5aLyc3w130_provenance.
- NP1293610.RAzr1hLyVGtVl15vGXlGFz3mjnmiWgQ_kBbWSE5aLyc3w130_assertion evidence source_evidence_literature NP1293610.RAzr1hLyVGtVl15vGXlGFz3mjnmiWgQ_kBbWSE5aLyc3w130_provenance.
- NP1293610.RAzr1hLyVGtVl15vGXlGFz3mjnmiWgQ_kBbWSE5aLyc3w130_assertion SIO_000772 26334901 NP1293610.RAzr1hLyVGtVl15vGXlGFz3mjnmiWgQ_kBbWSE5aLyc3w130_provenance.
- NP1293610.RAzr1hLyVGtVl15vGXlGFz3mjnmiWgQ_kBbWSE5aLyc3w130_assertion wasDerivedFrom befree-2016 NP1293610.RAzr1hLyVGtVl15vGXlGFz3mjnmiWgQ_kBbWSE5aLyc3w130_provenance.
- NP1293610.RAzr1hLyVGtVl15vGXlGFz3mjnmiWgQ_kBbWSE5aLyc3w130_assertion wasGeneratedBy ECO_0000203 NP1293610.RAzr1hLyVGtVl15vGXlGFz3mjnmiWgQ_kBbWSE5aLyc3w130_provenance.